Cytokinetics, Incorporated Loan Agreements
10 Contracts & Agreements
- 2024 Development Funding Loan Agreement, dated May 22, 2024, by and among Royalty Pharma Development Funding, LLC and the Company (Filed With SEC on August 9, 2024)
- Third Amendment, dated May 22, 2024, to Development Funding Loan Agreement, dated January 7, 2022, by and among Royalty Pharma Development Funding, LLC and the Company (Filed With SEC on August 9, 2024)
- Development Funding Loan Agreement, dated January 7, 2022, by and among Royalty Pharma Development Funding, LLC and the Company (Filed With SEC on February 25, 2022)
- Fourth Amendment to Loan and Security Agreement, dated June 30, 2021, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 5, 2021)
- Third Amendment to Loan and Security Agreement, dated July 16, 2020, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 6, 2020)
- Second Amendment to Loan and Security Agreement, dated as of November 7, 2019, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 13, 2019)
- First Amendment to Loan and Security Agreement, dated as of November 6, 2019, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 13, 2019)
- Loan and Security Agreement, dated as of May 17, 2019, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on August 9, 2019)
- Second Amendment to Loan and Security Agreement by and among the Company, Oxford Finance LLC and Silicon Valley Bank, dated as of October 27, 2017 (Filed With SEC on March 5, 2018)
- LOAN ANDSECURITY AGREEMENT (Filed With SEC on March 3, 2016)
